40298-25-7 Usage
Uses
Used in Organic Synthesis:
N-ME-PHE-OBZL P-TOSYLATE is used as a protecting group for the amino acid phenylalanine, ensuring that the amino group remains intact during chemical reactions. This selective protection is vital for the synthesis of complex organic molecules where the integrity of the amino group must be preserved.
Used in Pharmaceutical Compounds:
In the pharmaceutical industry, N-ME-PHE-OBZL P-TOSYLATE is utilized as a key intermediate in the development of various drug compounds. Its role in protecting the amino group of phenylalanine allows chemists to create sophisticated drug molecules with specific functionalities and therapeutic properties.
Used in Research and Development:
N-ME-PHE-OBZL P-TOSYLATE is also employed in research settings to explore new synthetic pathways and develop innovative methods for the synthesis of complex organic and pharmaceutical compounds. Its protective properties enable researchers to investigate the reactivity and selectivity of various chemical reactions involving phenylalanine derivatives.
Check Digit Verification of cas no
The CAS Registry Mumber 40298-25-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,0,2,9 and 8 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 40298-25:
(7*4)+(6*0)+(5*2)+(4*9)+(3*8)+(2*2)+(1*5)=107
107 % 10 = 7
So 40298-25-7 is a valid CAS Registry Number.
40298-25-7Relevant articles and documents
Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4
-
Page column 52-53, (2010/01/31)
Disclosed are compounds which bind VLA-4. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such compounds are useful in the treatment of inflammatory diseases in a mammalian patient, e.g., human, wherein the disease may be, for example, asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis and myocardial ischemia. The compounds can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis.
